Skip to main content
Helen Ward on Muck Rack

Helen Ward

London
As seen in: Color Research & Application, Nature, The Guardian, BMJ Open, MDPI, Sexually Transmitted Infections, Tes, Tes News (Podcast), Medscape, Scottish Daily Record and
Head of public affairs and communications at the Centre for Economic Performance, LSE. H.Ward1@lse.ac.uk Formerly wrote about education at @tes
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Helen

Contact Helen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Cognition and the menopause transition: cross-sectional evidence from a large community cohort

|
By Laura Naysmith, Helen Ward, Paul Elliott, Christina J Atchison, Peter Hellyer, Peter Denno, Steven Williams, Adam Hampshire
| Nature Verified
Abstract Subjective cognitive symptoms (brain fog, memory problems) are common in menopause, but whether these self-reported symptoms correspond to measurable deficits in cognition remains unclear. In 14,234 females (aged 45–55) from the REACT-Long Covid Study, we examined self-reported cognitive symptoms and objective cognitive performance in premenopausal, perimenopausal, postmenopausal participants. Global cognitive performance was derived from eight online tasks (‘Cognitron’).
Open in Who Shared Issue with article?

Profiling vaccine attitudes and subsequent uptake in 1·1 million people in England: a nationwide cohort study

|
By Matthew Whitaker, Joshua Elliott, Graham Cooke Verified, Helen Ward
| The Lancet Verified
Introduction Vaccine hesitancy—a reluctance or refusal to take a vaccine when offered—is a major public health challenge with complex determinants.
Open in Who Shared Issue with article?

The risk of Long Covid symptoms: a systematic review and meta-analysis of controlled studies - Nature Communications

|
By Lauren O’Mahoney, Ash Routen, Abdullah Almaqhawi, Daniel Ayoubkhani, Amitava Banerjee, Melanie Calvert, Shabana Cassambai, Mark Funnell, Rachael Evans, Shavez Jeffers, Roz Shafran, Terence Stephenson, Jonathan A. Sterne, Helen Ward, Tom Ward
| Nature Verified
Abstract The global evidence on the risk of symptoms of Long Covid in general populations infected with SARS-CoV-2 compared to uninfected comparator/control populations remains unknown. We conducted a systematic literature search using multiple electronic databases from January 1, 2022, to August 1, 2024. Included studies had ≥100 people with confirmed or self-reported COVID-19 at ≥28 days following infection onset, and an uninfected comparator/control group.
Open in Who Shared Issue with article?
See all 755 licensed articles (771 Total)